You can access the distribution details by navigating to My pre-printed books > Distribution
Beyond Generics: India’s Journey to Global Pharmaceutical Leadership — From Cost Advantage to Knowledge Sovereignty is a strategic and policy-oriented exploration of India’s transformation from a global supplier of affordable generic medicines to an emerging innovation-driven pharmaceutical power.
The book critically examines how India built its dominance in generics through manufacturing efficiency, regulatory agility, and scientific talent—while also addressing the structural limitations of a cost-based model. Moving beyond historical achievements, it presents a forward-looking blueprint for achieving pharmaceutical sovereignty through investment in new chemical entities (NCEs), biologics, biosimilars, API independence, regulatory science, intellectual property reform, digital health integration, and research-led education.
With analytical depth and national perspective, the book bridges industry, policy, academia, and entrepreneurship. It argues that the next phase of India’s pharmaceutical evolution must be knowledge-centric, innovation-driven, and globally competitive—anchored in ethical science and strategic autonomy.
More than a sectoral study, Beyond Generics is a call for India to transition from being the “pharmacy of the world” to becoming a global leader in pharmaceutical innovation and knowledge creation.
Currently there are no reviews available for this book.
Be the first one to write a review for the book Beyond Generics: India’s Journey to Global Pharmaceutical Leadership.